Protalix BioTherapeutics, Inc.

PLX ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
4 Jul 8, 2009 MAIN DOCUMENT DESCRIPTION
4 Jul 8, 2009 MAIN DOCUMENT DESCRIPTION
8-K Jul 6, 2009 FORM 8-K
8-K Jun 25, 2009 FORM 8-K
8-K Jun 4, 2009 FORM 8-K
8-K Jun 2, 2009 FORM 8-K
4 May 20, 2009 MAIN DOCUMENT DESCRIPTION
4 May 19, 2009 MAIN DOCUMENT DESCRIPTION
4 May 19, 2009 MAIN DOCUMENT DESCRIPTION
4 May 12, 2009 MAIN DOCUMENT DESCRIPTION
10-Q May 11, 2009 FORM 10-Q
4 May 6, 2009 MAIN DOCUMENT DESCRIPTION
4 Apr 20, 2009 MAIN DOCUMENT DESCRIPTION
UPLOAD Mar 23, 2009
CORRESP Mar 16, 2009
4 Mar 13, 2009 MAIN DOCUMENT DESCRIPTION
4 Mar 13, 2009 MAIN DOCUMENT DESCRIPTION
8-K Mar 11, 2009 FORM 8-K
10-Q/A Mar 6, 2009 AMENDMENT NO. 1 TO FORM 10-Q
10-Q/A Mar 6, 2009 AMENDMENT NO. 1 TO FORM 10-Q
10-Q/A Mar 6, 2009 AMENDMENT NO. 1 TO FORM 10-Q
10-K Mar 6, 2009 FORM 10-K
CORRESP Mar 4, 2009
4 Feb 27, 2009 MAIN DOCUMENT DESCRIPTION
4 Feb 27, 2009 MAIN DOCUMENT DESCRIPTION
← Newer Page 30 of 38 · 935 filings Older →